Intimation under regulation 30 of SEBI(LODR) regulations,2015-appointment of chief financial officer("CFO"), Key Managerial Personnel
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kimia Biosciences Ltd has appointed Mr. Naveen Sharma as its new Chief Financial Officer and Key Managerial Personnel, effective January 7, 2026. The appointment was approved by the Board of Directors at a meeting held the same day. Mr. Sharma is a Chartered Accountant with over 18 years of experience spanning finance, accounting, governance, and strategic leadership across financial services, EPC, manufacturing, and banking sectors. The disclosure was filed under SEBI LODR Regulation 30, with further details provided in Annexure A.
This is a routine KMP appointment with no immediate material impact on shareholders. Bringing in an experienced CFO with strong governance and compliance background may be viewed positively by investors focused on financial discipline and reporting quality.